Abstract
Background and Objectives
To evaluate the correlation between non-tumoral liver volume (NTLV) by computed tomography (CT) volumetry and indocyanine green retention at 15 minutes (ICG-r15%), Child–Pugh score (CTP) and model for end-stage liver diseases (MELD) score in cirrhotic patients having hepatocellular carcinoma (HCC) (group A) and in cirrhotics without HCC (group B).
Methods
As many as 111 consecutive patients with liver cirrhosis, who underwent triple-phase CT abdomen, were retrospectively included in our study. They were classified into group A (cirrhosis with HCC, n = 69) and group B (cirrhosis only, n = 42). Segmental liver volume, tumor and NTLV were calculated using Myrian XP-Liver segmentation software. In group B, NTLV was the same as the total liver volume (TLV). The correlation of NTLV with ICG-r15%, CTP and MELD scores was analyzed using appropriate correlation tests for each group.
Results
NTLV had a good and significant negative correlation with ICG-r15% (ρ = − 512; p < 0.001) in group A, but not in group B. It also had a significant negative correlation with CTP (ρ = − 251; p = 0.038) and MELD (ρ = − 323; p = 0.007) scores only in group A. Furthermore, ICG-r15% had a good and significant positive correlation with CTP and MELD scores in both groups (p < 0.05).
Conclusion
NTLV showed a significant negative correlation with ICG-r15% in cirrhotic patients with HCC, but not in cirrhotic patients without HCC. Therefore, CT volumetry can be a valuable tool to predict the functional hepatic volume in patients of cirrhosis with HCC subjected for hepatectomy, where a facility of ICG-r15% is not available. However, further studies are needed to validate our findings in cirrhotic only patients.
Graphical Abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Heidelbaugh JJ, Sherbondy M. Cirrhosis and chronic liver failure: part II. Complications and treatment. Am Fam Physician. 2006;74:767–76.
Mahmud N, Fricker Z, Hubbard RA, et al. Risk prediction models for post-operative mortality in patients with cirrhosis. Hepatology. 2021;73:204–18. https://doi.org/10.1002/hep.31558.
Rassam F, Olthof PB, Bennink RJ, van Gulik TM. Current modalities for the assessment of future remnant liver function. Visc Med. 2017;33:442–8. https://doi.org/10.1159/000480385.
De Gasperi A, Mazza E, Prosperi M. Indocyanine green kinetics to assess liver function: ready for a clinical dynamic assessment in major liver surgery? World J Hepatol. 2016;8:355–67. https://doi.org/10.4254/wjh.v8.i7.355.
Wang YY, Zhao XH, Ma L, et al. Comparison of the ability of Child-Pugh score, MELD score, and ICG-R15 to assess preoperative hepatic functional reserve in patients with hepatocellular carcinoma. J Surg Oncol. 2018;118:440–5. https://doi.org/10.1002/jso.25184.
Tu R, Xia LP, Yu AL, Wu L. Assessment of hepatic functional reserve by cirrhosis grading and liver volume measurement using CT. World J Gastroenterol. 2007;13:3956–61. https://doi.org/10.3748/wjg.v13.i29.3956.
Zhang JW, Feng XY, Liu HQ, et al. CT volume measurement for prognostic evaluation of unresectable hepatocellular carcinoma after TACE. World J Gastroenterol. 2010;16:2038–45. https://doi.org/10.3748/wjg.v16.i16.2038.
Durand F, Valla D. Assessment of the prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 2005;42:S100–7. https://doi.org/10.1016/j.jhep.2004.11.015.
Peng Y, Qi X, Guo X. Child-Pugh versus MELD score for the assessment of prognosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Medicine (Baltimore). 2016;95: e2877. https://doi.org/10.1097/MD.0000000000002877.
Seyama Y, Kokudo N. Assessment of liver function for safe hepatic resection. Hepatol Res. 2009;39:107–16. https://doi.org/10.1111/j.1872-034X.2008.00441.x.
Møller S, la Cour SE, Madsen JL, Bendtsen F. Indocyanine green retention test in cirrhosis and portal hypertension: accuracy and relation to severity of disease. J Gastroenterol Hepatol. 2019;34:1093–9. https://doi.org/10.1111/jgh.14470.
Shalimar, Jain S, Gamanagatti SR, et al. Role of indocyanine green in predicting post-transarterial chemoembolization liver failure in hepatocellular carcinoma. J Clin Exp Hepatol. 2018;8:28–34. https://doi.org/10.1016/j.jceh.2017.05.012.
Jeong EM, Hwang SG, Park HH, et al. The anaylsis of mortality rate according to CTP score and MELD score in patients with liver cirrhosis. Korean J Hepatol. 2003;9:98–106.
Lim MC, Tan CH, Cai J, Zheng J, Kow AW. CT volumetry of the liver: where does it stand in clinical practice? Clin Radiol. 2014;69:887–95. https://doi.org/10.1016/j.crad.2013.12.021.
Goumard C, Perdigao F, Cazejust J, Zalinski S, Soubrane O, Scatton O. Is computed tomography volumetric assessment of the liver reliable in patients with cirrhosis? HPB (Oxford). 2014;16:188–94. https://doi.org/10.1111/hpb.12110.
Ferrero A, Viganò L, Polastri R, et al. Postoperative liver dysfunction and future remnant liver: where is the limit? Results of a prospective study. World J Surg. 2007;31:1643–51. https://doi.org/10.1007/s00268-007-9123-2.
Ozaki K, Matsui O, Kobayashi S, Minami T, Kitao A, Gabata T. Morphometric changes in liver cirrhosis: aetiological differences correlated with progression. Br J Radiol. 2016;89:20150896. https://doi.org/10.1259/bjr.20150896.
Matsumoto Y, Fujii H, Matsuda M, Kono H. Multicentric occurrence of hepatocellular carcinoma: diagnosis and clinical significance. J Hepatobiliary Pancreat Surg. 2001;8:435–40. https://doi.org/10.1007/s005340100006.
Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics. 2008;28:747–69. https://doi.org/10.1148/rg.283055108.
Elsawy AA, Dawoud MM, Elarabawy RA, Mohamed WS, Dawoud RM. Role of residual liver volumetry and function in prediction of liver tolerability after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients: deriving a clinical decision support score. Egypt J Radiol Nucl Med. 2020;51:1–3.
Author information
Authors and Affiliations
Contributions
YP, KM, SKS: conceptualized the study design; YP, KM, RKP, SST: collected the data, analyzed the data; YP, KM, RKP: prepared the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
YP, KM, RKP, SST and SKS declare no competing interests.
Ethics statement
The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.
Disclaimer
The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Patidar, Y., Mittal, K., Patel, R.K. et al. Liver volumetry in cirrhotic patients with or without hepatocellular carcinoma: Its correlation with Child–Pugh, model for end-stage liver diseases and indocyanine green dye test. Indian J Gastroenterol (2024). https://doi.org/10.1007/s12664-023-01490-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12664-023-01490-1